Primary Site >> Liver Cancer
Gene >> CYP3A5
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43. PMID: 12679136 Ref: CYP3A5*1 is an inhibitory factor for lung cancer in Taiwanese. PMID: 12822676 |
Ref: Cytochrome P450 gene polymorphism and cancer. PMID: 15180491 Ref: Increased levels of aflatoxin-albumin adducts are associated with CYP3A5 polymorphisms in The Gambia, West Africa. PMID: 15454734 |
Ref: Patterns of expression of cytochrome P450 genes in progression of hepatitis C virus-associated hepatocellular carcinoma. PMID: 16077914 |
Ref: Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients. PMID: 17605821 Ref: [A case-control study on the association of hepatocellular carcinoma with genetic polymorphisms of CYP3A5 in a highly aflatoxin B1 contaminated Guangxi area]. PMID: 17903382 |
Ref: Population pharmacokinetic analysis of sorafenib in patients with solid tumours. PMID: 21392074 |
Ref: CYP3A5*3 polymorphism and cancer risk: a meta-analysis and meta-regression. PMID: 23584898 |
Ref: Expression of P450 and nuclear receptors in normal and end-stage Chinese livers. PMID: 25024626 |
Ref: CYP3A5 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Regulating mTORC2/Akt Signaling. PMID: 25649767 |
Ref: Significant change of cytochrome P450s activities in patients with hepatocellular carcinoma. PMID: 27203676 |
Ref: Gene Variations of Sixth Complement Component Affecting Tacrolimus Metabolism in Patients with Liver Transplantation for Hepatocellular Carcinoma. PMID: 28685716 |
Ref: The down-regulation of the CYP2C19 gene is associated with aggressive tumor potential and the poorer recurrence-free survival of hepatocellular carcinoma. PMID: 29774122 Ref: The prognostic value of differentially expressed CYP3A subfamily members for hepatocellular carcinoma. PMID: 29983591 Ref: Specific CYP450 Genotypes in the Chinese Population Affect Sorafenib Toxicity in HBV/HCV-associated Hepatocellular Carcinoma Patients. PMID: 30231963 |